infantile idiopathic nephrotic syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients newly diagnosed with pediatric idiopathic nephrotic syndrome after approval by the Ethics Committee (including patients transferred to the hospital before (or during) the initial treatment) (2) 999 patients enrolled in an existing study (JP-SHINE Study) (3) Patients aged between 6 months and 15 years at the time of diagnosis
Exclusion criteria
Exclusion criteria: (i) Patients deemed inappropriate for this study by the physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of cases that progressed to refractory nephrotic syndrome as a percentage of total enrollment Time to refractoriness | — |
Countries
Japan
Contacts
Kitasato University Faculty of Medicine